Ratings Balaji Amines Limited

Equities

BALAMINES

INE050E01027

Delayed Bombay S.E. Other stock markets 02:38:08 2024-06-03 am EDT			5-day change	1st Jan Change
2,110 ^INR	+0.89%		-3.05%	-20.94%

May. 10	Transcript : Balaji Amines Limited, Q4 2024 Earnings Call, May 10, 2024
May. 08	Balaji Amines' Consolidated Profit Jumps in Fiscal Q4; Shares Surge 10%	MT

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
According to Refinitiv, the company's ESG score for its industry is poor.

Strengths

The group's high margin levels account for strong profits.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 33.46 times its estimated earnings per share for the ongoing year.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the past year, analysts have significantly revised downwards their profit estimates.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
BALAJI AMINES LIMITED	-20.94%	812M	D+
ECOLAB INC.	+17.07%	66.31B	A-
SIKA AG	-0.29%	48.46B	A-
GIVAUDAN SA	+21.61%	43.27B	B+
FUJIFILM HOLDINGS CORPORATION	+27.43%	27.41B	A-
EMS-CHEMIE HOLDING AG	+9.25%	19.26B	C+
CELANESE CORPORATION	-2.14%	16.61B	B+
SYMRISE AG	+9.75%	16.58B	B+
ALBEMARLE CORPORATION	-15.01%	14.41B	C+
POSCO FUTURE M CO., LTD.	-30.22%	14.02B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes